Since its foundation, Burrill has built worldwide capabilities unmatched by other boutique Life Sciences banking firms, including:

• A multicultural, multilingual team spanning the globe
• Extensive international business relationships
• Worldwide pharmaceutical regulatory and marketing experience

These capabilities are particularly important in this ever-shrinking world, as the dynamics of technologies, end-markets and capital increasing operate on a global scale.

Ways Burrill can bring its international capabilities to bear include:

• Capital Access - Assisting companies worldwide in accessing the attractive and dominant United States investment market
• Technology Access - Cross-border buyside and sellside activities for companies looking to expand their technology portfolio
• Market Access - In-licensing and out-licensing projects to take advantage of emerging global markets